Diverse microtubule-targeted anticancer agents kill cells by inducing chromosome missegregation on multipolar...

Area of Science:

• Oncology
• Cell Biology
• Genetics

Background:

• Microtubule-targeted agents are standard cancer treatments, but patient response varies.
• Current understanding suggests these drugs work by causing mitotic arrest, leading to cell death.
• Recent findings indicate intratumoral drug concentrations may be too low for mitotic arrest, suggesting alternative mechanisms.

Purpose of the Study:

• To investigate the conserved mechanisms of action for clinically relevant microtubule poisons.
• To explore the role of chromosomal instability (CIN) in cancer treatment response.
• To identify mechanisms of resistance to microtubule-targeted therapies.

Main Methods:

• Utilized metastatic breast cancer and human cellular models.
• Employed a novel method to quantify the rate of chromosomal instability (CIN).
• Assessed the impact of spindle focusing and additional drugs on CIN and cell death.

Main Results:

• Clinically useful microtubule poisons induce CIN via multipolar mitotic spindles, not mitotic arrest.
• Cell death positively correlates with net DNA loss, a consequence of CIN.
• Decreased CIN through spindle focusing leads to resistance to microtubule poisons.
• Resistance can be overcome by drugs that increase CIN without altering spindle polarity.

Conclusions:

• The mechanism of inducing CIN via multipolar spindles is conserved across various microtubule poisons.
• Spindle focusing represents a conserved resistance mechanism to these agents.
• Understanding these conserved mechanisms can inform the development of more effective cancer therapies.